175968-61-3

Basic information

• Product Name: 4-(benzyloxy)-3-fluorobenzaldehyde
• Synonyms: 4-(benzyloxy)-3-fluorobenzaldehyde;3-fluoro-4-phenylmethoxybenzaldehyde
• CAS NO: 175968-61-3
• Molecular Formula: C₁₄H₁₁FO₂
• Molecular Weight: 230.237
• Mol File: 175968-61-3.mol
• Article Data: 21

Chemical Properties

• Melting Point: 94-95 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3))
• Boiling Point: 371.5±27.0 °C(Predicted)
• Appearance: /
• Density: 1.211±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-(benzyloxy)-3-fluorobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(benzyloxy)-3-fluorobenzaldehyde(175968-61-3)
• EPA Substance Registry System: 4-(benzyloxy)-3-fluorobenzaldehyde(175968-61-3)

Safety Data

• Hazardous Substances Data: 175968-61-3(Hazardous Substances Data)

Usage

General Description

The chemical 4-(benzyloxy)-3-fluorobenzaldehyde, also known as 3-fluoro-4-(phenylmethoxy)benzaldehyde, is an organic compound with the molecular formula C14H11FO2. It is a white to off-white crystalline solid that is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. 4-(benzyloxy)-3-fluorobenzaldehyde is often used as a building block in the production of various organic compounds due to its reactivity and versatility. Its aromatic structure and functional groups make it a valuable starting material for the synthesis of more complex molecules. Additionally, it is important to handle this chemical with care as it may pose hazards if mishandled or improperly used.

Upstream product

• 405-05-0 3-fluoro-4-hydroxybenzaldehyde 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 100-51-6 benzyl alcohol 
• 405-04-9 3-fluoro-4-hydroxybenzonitrile 
• 351-54-2 3-fluoro-p-anisaldehyde 
• 4394-85-8 4-morpholinecarboxaldehyde 
• 133057-82-6 1-benzyloxy-4-bromo-2-fluorobenzene 
• 1044067-62-0 4-(benzyloxy)-3-fluorobenzonitrile 

Downstream Products

• 536974-94-4 [4-(benzyloxy)-3-fluorophenyl]methanol 
• 638214-82-1 ethyl (2E)-3-{3-fluoro-4-[(phenylmethyl)oxy]phenyl}-2-propenoate 
• 1240308-56-8 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid 
• 1337991-95-3 2-(4-benzyloxy-3-fluorophenyl)-4-bromo-5-propyltetrahydropyran 
• 839694-31-4 methyl 3-(4-(benzyloxy)-3-fluorophenyl)acrylate 
• 668478-41-9 [rac]-3-(4-benzyloxy-3-fluoro-phenyl)-2-isopropoxy-propionic acid ethyl ester 
• 94139-03-4 ethyl 3-(3-fluoro-4-hydroxyphenyl)-2-propanoate 
• 922719-77-5 4-benzyloxy-3-fluorobenzylbromide 

Relevant articles and documents

BIFUNCTION CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE

The present disclosure relates to bifunctional chemical epigenetic modifiers, and methods of making, kits and using the bifunctional chemical epigenetic modifiers. The bifunctional chemical epigenetic modifiers can include a FK506 molecule or derivative thereof, a linker and a bifunctional ligand. The bifunctional ligand can be a histone deacetylase inhibitor.

RNAI AGENTS FOR INHIBITING EXPRESSION OF HIF-2 ALPHA (EPAS1), COMPOSITIONS THEREOF, AND METHODS OF USE

The present disclosure relates to RNAi agents, for example, double stranded RNAi agents, able to inhibit HIF-2 alpha ( EPAS1 ) gene expression. Also disclosed are pharmaceutical compositions that include HIF-2 alpha RNAi agents and methods of use thereof. The HIF-2 alpha RNAi agents disclosed herein may be linked or conjugated to targeting ligands (such as compounds that have affinity for integrins, including alpha-v-beta-3 and alpha-v-beta-5 integrins) and pharmacokinetic (PK) enhancers, to facilitate the delivery to cells and tissues, including to clear cell renal cell carcinoma (ccRCC) cells and tumors. Delivery of compositions comprising the HIF-2 alpha RNAi agents in vivo provides for inhibition of HIF-2 alpha gene expression. The HIF-2 alpha RNAi agents can be used in methods of treatment of various diseases and disorders, including ccRCC.

LEUKOTRIENE SYNTHESIS INHIBITORS

Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.